Editorial commentary: New challenges in the elimination of pediatric HIV infection: The expanding population of HIV-exposed but uninfected children

Clinical Infectious Diseases

Volumn 60, Issue 9, 2015, Pages 1357-1360

  Mofenson, Lynne M ^a  

^a ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION   (United States)

Author keywords

Antiretroviral; HIV; HIV exposed uninfected children; Pediatric

Indexed keywords

ADAPTIVE IMMUNITY; CHILD; EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INFANT MORTALITY; INFECTION RISK; MIXED INFECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; FEMALE; MALE; MICROBIOLOGY; MORTALITY; PNEUMOCOCCAL INFECTIONS;

FEMALE; HIV INFECTIONS; HUMANS; MALE; PNEUMOCOCCAL INFECTIONS;

EID: 84928882537     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ064     Document Type: Note

References (49)

1. World Health Organization. Global update on the health sector response to HIV, 2014. Geneva, Switzerland: WHO, 2014. Available at: http://www.who.int/hiv/pub/progressreports/update2014/en/. Accessed 5 February 2015.
2. United Nations Joint Programme on HIV/AIDS. Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. Geneva, Switzerland: WHO, 2011. Available at: http://www.zero-hiv.org/wp-content/uploads/2014/06/Global-Plan-Elimination-HIV-Children-Eng.pdf. Accessed 5 February 2015.
3. United States President's Emergency Plan for AIDS Relief (PEPFAR). Tenth Annual Report to Congress. Available at: http://www. pepfar.gov/press/222853.htm. Accessed 5 February 2015.
4. Joint United Nations Programme on HIV/AIDS. The gap report 2014. Geneva, Switzerland: UNAIDS, 2014. Available at: http://www.unaids.org/sites/default/files/media- asset/UNAIDS-Gap-report-en.pdf. Accessed 5 February 2015.
5. Filteau S. The HIV-exposed, uninfected African child. Trop Med Internat Health 2009; 14:276-87.
6. Heidari S, Mofenson L, Cotton MF, et al. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but unin-fected children. J Acquir Immune Defic Syndr 2011; 57:290-6.
7. von Mellendorf C, von Gottberg A, Tempia S, et al. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013. Clin Infect Dis 2015; 60:1346-56.
8. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004; 364:1236-43.
9. McNally LM, Jeeena PM, Gajee K, et al. Effect of age, polymicrobial disease and maternal HIV status on treatment response and cause of severe pneumonia in South Africa children: a prospective descriptive study. Lancet 2007; 369:1440-51.
10. Marinda E, Humphrey JH, Iliff PJ, et al. Child mortality according to maternal and infant HIV status in Zimbabwe. Pediatr Infect Dis J 2007; 26:519-26.
11. Slogrove AL, Cotton MF, Esser MM. Severe infections HIV-exposed uninfected infants: clinical evidence of immunodeficiency. J Trop Pediatr 2010; 56:75-81.
12. Koyanagi A, Humphrey JH, Ntozini R, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J 2011; 30:45-51.
13. Slogrove A, Reikie B, Naidoo S, et al. HIV-exposed uninfected infants are at increased risk for severe infections in the first year of life. J Trop Pediatr 2012; 58:505-8.
14. Cotton MF, Slogrove A, Rabie H. Infections in HIV-exposed uninfected children with a focus on sub-Saharan Africa. Pediatr Infect Dis J 2014; 33:1085-6.
15. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin America and Caribbean countries: the National Institute of Child Health and Human Development Site Development Initiative Perinatal Study. Pediatrics 2008; 119: e694-704.
16. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics 2010; 126:e631-8.
17. Taron-Brocard C, Le Chenadec J, Faye A, et al. Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country. Clin Infect Dis 2014; 59:1332-45.
18. Afran L, Garcia Knight M, Nduati E, et al. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol 2013; 176:11-22.
19. Sugandhi N, Rodrigues J, Kim M, et al. HIV-exposed infants: rethinking care for a lifelong condition. AIDS 2013; 27(suppl 2): S187-95.
20. Kuhn L, Kasonde P, Sinkala M, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their infected infants? Clin Infect Dis 2005; 41:1654-61.
21. Kakkar F, Lamarre V, Ducruet T, et al. Impact of maternal HIV-1 viremia on lymphocyte subsets among HIV-exposed uninfected infants: protective mechanism or immunodeficiency. BMC Infect Dis 2014; 14:236.
22. Jao J, Abrams E. Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants. Pediatr Infect Dis J 2014; 33:734-40.
23. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med 2009; 27:358-68.
24. Feuer SK, Liu X, Donjacour A, et al. Use of a mouse in vitro fertilization model to understand the developmental origins of health and disease hypothesis. Endocrinology 2014; 155:1956-69.
25. El Hajj N, Schneider E, Lehnen H, Haaf T. Epigenetics and life-long consequences of an adverse nutritional and diabetic intrauter-ine environment. Reproduction 2014; 148: R111-20.
26. Dauby N, Goetghebuer T, Kollmann TR, Levy J, Marchant A. Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections. Lancet 2012; 12:330-40.
27. De Moraes-Pinto MI, Almeida ACM, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173:1077-84.
28. Scott S, Moss WJ, Cousens S, et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007; 45:1417-24.
29. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305:576-84.
30. Le Doare K, Allen L, Kampmann B, et al. Anti-group B streptococcus antibody in infants born to mothers with human immunodeficiency virus (HIV) infection. Vaccine 2014; 33:621-7.
31. Gaensbauer JT, Rakhola JT, Onyango-Makumbi C, et al. Impaired Haemophilus in-fluenzae Type b transplacental antibody transmission and declining antibody avidity through the first year of life represent potential vulnerabilities for HIV-exposed but-uninfected infants. Clin Vaccine Immunol 2014; 21:1661-7.
32. Reikie BA, Adams RCM, Leligdowicz A, et al. Altered innate immune development in HIV-exposed uninfected infants. J Acquir Immune Defic Syndr 2014; 66:245-55.
33. Clerici M, Saresella M, Colombo F, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood 2000; 96: 3866-71.
34. Abramczuk BM, Mazzola TN, Moreno YMF, et al. Impaired humoral response to vaccines among HIV-exposed uninfected infants. Clin Vaccine Immunol 2011; 18:1406-9.
35. Simani OE, Adrian PV, Violari A, et al. Effect of in utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS 2013; 27:1583-91.
36. Kidzeru EB, Hesseling AC, Passmore JS, et al. In utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants. AIDS 2014; 28:1421-30.
37. Chen JY, Ribaudo HJ, Souda S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis 2012; 206:1695-705.
38. Watts DH, Mofenson LM. Antiretrovirals in pregnancy: a note of caution. J Infect Dis 2012; 206:1639-41.
39. Le Chenadec J, Mayaux MJ, Gihenneuc-Jouyaux C, Blanche S. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 2003; 17:2053-61.
40. European Collaborative Study. Levels and patterns of neutrophil counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS 2004; 18:2009-17.
41. Pacheco SE, McIntosh K, Lu M, et al. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: an analysis of the Women and Infants Transmission Study. J Infect Dis 2006; 194: 1089-97.
42. Moren C, Noguera-Julian A, Garrabou G, et al. Mitochondrial disturbances in HIV pregnancies. AIDS 2015; 29:5-12.
43. Simon A, Warszawski J, Kariyawasam D, et al. Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers. JAMA 2011; 306: 70-8.
44. Kirmse B, Hobbs CV, Peter I, et al. Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants. Pediatr Infect Dis J 2013; 32:146-50.
45. Izadnegahdar R, Fox MP, Jeena P, et al. Revisiting pneumonia and exposure status in infants born to HIV-infected mothers. Pediatr Infect Dis J 2014; 33:70-2.
46. Kuhn L, Sinkala M, Semrau K, et al. Elevations in mortality associated with weaning persists into the second year of life among uninfected children born to HIV-in-fected mothers. Clin Infect Dis 2010; 50: 437-44.
47. Bork KA, Cournil A, Read JS, et al. Morbidity in relation to feeding mode in African HIV-exposed, uninfected infants during the first 6 mo of life: the Kesho Bora study. Am J Clin Nutr 2014; 100:1559-68.
48. Marquez C, Okiring J, Chamie G, et al. Increased morbidity in early childhood among HIV-exposed uninfected children in Uganda is associated with breastfeeding duration. J Trop Pediatr 2014; 60:434-41.
49. Asbjornsdottir KH, Slyker JA, Weiss NS, et al. Breastfeeding is associated with decreased pneumonia incidence among HIV-exposed, uninfected Kenyan infants. AIDS 2013; 27:2809-15.